ICU Medical Inc is recalling over 3 million bags of Hospira brand Sodium Chloride and Dextrose Injections because the bags may leak, which could lead to a loss of sterility. The recall affects 0.45% Sodium Chloride (100 mL), 0.9% Sodium Chloride (100 mL and 250 mL), and 5% Dextrose (250 mL) injections used in medical settings. If the sterility of these intravenous fluids is compromised, it could lead to serious infections in patients receiving the medication.
A leaking bag can allow bacteria and other contaminants to enter the fluid, compromising the sterility required for intravenous injections. This poses a risk of infection or systemic illness for any patient receiving the affected medication.
Contact healthcare provider and return product.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.